Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tau and Amyloid Imaging in Stroke Prognosis
NCT04572477Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jun 2017
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 2, open-label trial (3 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoints: Imaging positive and negative conditions at 1.5 years and Dementia conversion rate at 1.5 years. Status: unknown.
Beyond the preview
Go deeper on NCT04572477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04572477.